Behavioral aspects of pediatric epilepsy syndromes

Frank M C Besag1

  • 1Twinwoods Health Resource Centre, Milton Road, Bedford MK41 6AT, UK. FBesag@aol.com

Epilepsy & Behavior : E&B
|January 17, 2004
PubMed

Insights

Epilepsy syndromes in children are linked to various behavioral issues, including autism, hyperactivity, and aggression. Early treatment may improve cognitive and behavioral outcomes, but more research is needed to confirm these findings.

Area of Science:

  • Pediatric Neurology
  • Developmental Neuroscience

Background:

  • Cognition and behavior are crucial for a child with epilepsy's independence.
  • Epilepsy syndrome diagnosis informs seizure control and intellectual outcomes.
  • Limited research exists on the behavioral aspects of various epilepsy syndromes.

Purpose of the Study:

  • To review and synthesize the current understanding of behavioral issues associated with specific childhood epilepsy syndromes.
  • To highlight the potential impact of early treatment on cognitive and behavioral outcomes.
  • To identify gaps in research regarding behavioral disturbances in pediatric epilepsy.

Main Methods:

  • Literature review of published studies on behavioral aspects of childhood epilepsy syndromes.
  • Synthesis of reported behavioral characteristics in West syndrome, Dravet syndrome, Lennox-Gastaut syndrome, Landau-Kleffner syndrome, benign partial seizures with centrotemporal spikes, and juvenile myoclonic epilepsy.
  • Discussion of the association between specific epilepsy syndromes and behavioral comorbidities like autism, hyperactivity, and aggression.

Main Results:

  • West syndrome: Emerging evidence suggests early treatment may improve cognition and behavior; association between temporal lobe tubers and autism noted.
  • Dravet syndrome: Associated with hyperactivity and autistic features; often treatment-resistant.
  • Lennox-Gastaut syndrome: Behavioral problems include autistic features and sluggishness, likely due to ongoing seizures.
  • Landau-Kleffner syndrome: Autistic features, aggression, and hyperkinesis described; behavior may improve with treatment.
  • Benign partial seizures with centrotemporal spikes: Behavioral issues like concentration difficulties, hyperactivity, and impulsivity can occur.
  • Juvenile myoclonic epilepsy: Linked to variable behavioral traits, potentially indicating frontal lobe dysfunction.

Conclusions:

  • Specific epilepsy syndromes are associated with distinct behavioral profiles, including autistic features, hyperactivity, and aggression.
  • Early and effective treatment of epilepsy, particularly in syndromes like West syndrome, shows promise for improving cognitive and behavioral outcomes.
  • Further prospective studies using validated measures are essential to establish firm conclusions and understand the impact of successful epilepsy treatment on behavior.

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...